Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Drug Discovery Today|May 26, 2023
Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discoverySathapana Kongsamut, Haifeng EishingdreloCurrent Chemical Genomics and Translational Medicine|January 8, 2014
Minireview: Targeting GPCR Activated ERK Pathways for Drug DiscoveryHaifeng Eishingdrelo, Sathapana KongsamutSignal Transduction and Targeted Therapy|December 22, 2017
G-protein-coupled receptors mediate 14-3-3 signal transductionHua Li, Alex Eishingdrelo, Sathapana Kongsamut, et al.Current Research in Pharmacology and Drug Discovery|August 22, 2022
Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoformsHaifeng Eishingdrelo, Xiaofa Qin, Luwa Yuan, et al.European Journal of Pharmacology|August 15, 2002
A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugsSathapana Kongsamut, Jiesheng Kang, Xiao-Liang Chen, et al.Clinical and Experimental Pharmacology & Physiology|May 6, 2009
In Vitro electrophysiological activity of nerispirdine, a novel 4-aminopyridine derivativeCraig Smith, Sathapana Kongsamut, Hongge Wang, et al.Scientific Reports|August 3, 2019
14-3-3 signal adaptor and scaffold proteins mediate GPCR traffickingLuwa Yuan, Shahar Barbash, Sathapana Kongsamut, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 GroupGuyan Liang, Xin Chen, Suzanne Aldous, et al.Scientific Reports|October 14, 2016
The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaGuy Griebel, Philippe Pichat, Denis Boulay, et al.Pageof 1